Cover Image
Market Research Report

Biodefense

Published by Global Industry Analysts, Inc. Product code 959326
Published Content info 150 Pages
Delivery time: 1-2 business days
Price
Back to Top
Biodefense
Published: September 1, 2020 Content info: 150 Pages
Description

Global Biodefense Market to Reach US$19.5 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Biodefense estimated at US$13.5 Billion in the year 2020, is projected to reach a revised size of US$19.5 Billion by 2027, growing at a CAGR of 5.4% over the period 2020-2027.Vaccines, one of the segments analyzed in the report, is projected to grow at a 5.6% CAGR to reach US$12.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biothreat Detection Devices segment is readjusted to a revised 5.1% CAGR for the next 7-year period. This segment currently accounts for a 37.1% share of the global Biodefense market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 5% CAGR for the Period of 2020-2027

The Biodefense market in the U.S. is estimated at US$4 Billion in the year 2020. The country currently accounts for a 29.48% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$3.4 Billion in the year 2027 trailing a CAGR of 5% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR while Rest of European market (as defined in the study) will reach US$3.4 Billion by the year 2027.We bring years of research experience to this 17th edition of our report. The 150-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Achaogen, Inc.
  • Alexeter Technologies, LLC
  • Alnylam Pharmaceuticals, Inc.
  • Altimmune, Inc.
  • ANP Technologies, Inc.
  • Bavarian Nordic A/S
  • Cleveland BioLabs, Inc.
  • Elusys Therapeutics, Inc.
  • Emergent BioSolutions, Inc.
  • Ichor Medical Systems, Inc.
  • New Horizons Diagnostic Corporation
  • PathSensors, Inc.
  • Research International, Inc.
  • SIGA Technologies
Table of Contents
Product Code: MCP-1831

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Global Competitor Market Shares
    • Biodefense Competitor Market Share Scenario Worldwide (in %): 2018E
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 2: World Historic Review for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 3: World 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
    • TABLE 4: World Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 5: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 6: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
    • TABLE 7: World Current & Future Analysis for Biothreat Detection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 8: World Historic Review for Biothreat Detection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 9: World 15-Year Perspective for Biothreat Detection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Biodefense Market Share (in %) by Company: 2018 &
    • Market Analytics
    • TABLE 10: USA Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 11: USA Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 12: USA 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • CANADA
    • TABLE 13: Canada Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 14: Canada Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 15: Canada 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • JAPAN
    • TABLE 16: Japan Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 17: Japan Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 18: Japan 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • CHINA
    • TABLE 19: China Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 20: China Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 21: China 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Biodefense Market: Competitor Market Share Scenario (in %) for 2018 &
    • Market Analytics
    • TABLE 22: Europe Current & Future Analysis for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 23: Europe Historic Review for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 24: Europe 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027
    • TABLE 25: Europe Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 26: Europe Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 27: Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • FRANCE
    • TABLE 28: France Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 29: France Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 30: France 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • GERMANY
    • TABLE 31: Germany Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 32: Germany Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 33: Germany 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • ITALY
    • TABLE 34: Italy Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 35: Italy Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 36: Italy 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • UNITED KINGDOM
    • TABLE 37: UK Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 38: UK Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 39: UK 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • REST OF EUROPE
    • TABLE 40: Rest of Europe Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 41: Rest of Europe Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 42: Rest of Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • ASIA-PACIFIC
    • TABLE 43: Asia-Pacific Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 44: Asia-Pacific Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 45: Asia-Pacific 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027
  • REST OF WORLD
    • TABLE 46: Rest of World Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 47: Rest of World Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 48: Rest of World 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027

IV. COMPETITION

  • Total Companies Profiled: 54
Back to Top